Salt-induced downregulation of renal aquaporins is prevented by losartan

Regul Pept. 2012 Aug 20;177(1-3):85-91. doi: 10.1016/j.regpep.2012.05.090. Epub 2012 May 12.

Abstract

Aims: The purpose of this study was to investigate the expression of aquaporin-1 (AQP-1) and aquaporin-2 (AQP-2) in the renal tubule of rats fed with a high-salt diet and its modulation by the AT1 receptor blocker losartan.

Main methods: The experiments were performed in four groups of rats fed for 3 weeks with the following diets: regular rat chow (NS); high-salt (8% NaCl) chow (HS), NS plus losartan (NS-L) and HS plus losartan (HS-L). Losartan (40 mg x kg(-1)) was administered in the drinking water. Systolic blood pressure (SBP) and renal function were evaluated. The intrarenal levels of angiotensin II (Ang II), TGF-β(1), α-smooth muscle actin (α-SMA), endothelial nitric oxide synthase (eNOS), AQP-1 and AQP-2 were determined by immunohistochemistry. AQP-1 and AQP-2 protein levels were measured by western blot analysis.

Key findings: A high-sodium diet downregulated AQP-1 and AQP-2 expression levels in the proximal tubule and collecting duct, respectively. The high-sodium diet also induced Ang II, TGF-β(1) and α-SMA overexpression and decreased eNOS expression in the renal cortex and medulla. Losartan increased the diuresis and natriuresis, favoring urinary sodium concentration. Additionally, losartan prevented the profibrogenic response, decreasing Ang II, TGF-β(1) and α-SMA levels and normalizing AQP-2 expression in the HS-L group. AQP-1 expression was upregulated by losartan in both the NS-L and HS-L groups.

Significance: These results show that increased intrarenal Ang II in rats fed with a high-salt diet downregulates renal AQP-1 and AQP-2 expressions. In addition, although losartan increased diuresis and natriuresis, it prevented the downregulation of aquaporins, favoring urinary sodium concentration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Angiotensin II / metabolism
  • Angiotensin II Type 2 Receptor Blockers / pharmacology
  • Animals
  • Aquaporin 1 / metabolism*
  • Aquaporin 2 / metabolism*
  • Blood Pressure / drug effects
  • Blotting, Western
  • Down-Regulation
  • Drinking Water / administration & dosage
  • Immunohistochemistry
  • Kidney Cortex / drug effects
  • Kidney Cortex / metabolism
  • Kidney Function Tests
  • Kidney Tubules / drug effects*
  • Kidney Tubules / metabolism
  • Losartan / pharmacology*
  • Male
  • Natriuresis
  • Nitric Oxide Synthase Type III / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Angiotensin, Type 2 / metabolism
  • Sodium Chloride, Dietary / administration & dosage
  • Sodium Chloride, Dietary / adverse effects*
  • Transforming Growth Factor beta1 / metabolism

Substances

  • Actins
  • Angiotensin II Type 2 Receptor Blockers
  • Aqp1 protein, rat
  • Aqp2 protein, rat
  • Aquaporin 2
  • Drinking Water
  • Receptor, Angiotensin, Type 2
  • Sodium Chloride, Dietary
  • Transforming Growth Factor beta1
  • smooth muscle actin, rat
  • Angiotensin II
  • Aquaporin 1
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat
  • Losartan